Companies/Concord Medical Services Holdings Limited

Company profile

Concord Medical Services Holdings Limited

NYSE: CCM · Healthcare · Medical - Care Facilities

PublicHQ Beijing, NYCIK 0001472072Reports USD

#400 of 1,394 Healthcare companies by revenue71st-percentile growth

EA Score

58C

FH 66DQ 50GM 52SS 60

v0.1 · 65/100 weight · provisional

↑ disclosure history, Piotroski F · ↓ filing timeliness, market scale

Methodology →

Revenue TTM

$65.0M

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$13.3M

Employees

595

Market cap

$627.6k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$65.0M$65.0M2025

Net income-$13.3M-$13.3M2025

Operating income-$37.4M-$37.4M2025

Total assets$936.3M$936.3M2025

Liabilities$671.7M$671.7M2025

Equity-$300.7M-$300.7M2025

Revenue trend

FY2018 – FY2025 · USD

$27.8M

FY18

$20.1M

FY19

$26.1M

FY20

$69.5M

FY21

$65.3M

FY22

$73.3M

FY23

$51.3M

FY24

$65.0M

FY25

Revenue by segment

Filed disclosures · FY2025

By product

Services and other revenues81%

Medicine income17%

Equipment Leasing Revenues2%

By geography

Not disclosed.

The read

Concord Medical Services Holdings Limited booked $65.0M in FY2025 revenue, growing 27% year over year — faster than most Healthcare companies we track, at a -20.4% net margin.

Peers · Healthcare

ChitogenX Inc.——Molecule Holdings Inc.——StageZero Life Sciences Ltd.——Pharmagreen Biotech Inc.——

Key facts

CEOJianyu Yang

SectorHealthcare

IndustryMedical - Care Facilities

HeadquartersBeijing, NY

ExchangeNYSE: CCM

Employees595

IPO date2009-12-11

Latest filings

6-K2026-07-02 6-K2026-05-18 6-K2026-05-13 6-K2026-05-13 20-F2026-04-29 6-K2026-04-15 6-K2025-12-02 6-K2025-09-30

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.